A recent publication by the British Thoracic Society offers the first long-term analysis of the UK Idiopathic Pulmonary ...

Dr Ahmed Fahim discusses the UK Idiopathic Pulmonary Fibrosis Registry and how its findings enhance understanding and ...

The abnormal accumulation of antibody-producing immune cells in the lungs may contribute to IPF progression, a new study ...

Piezo2 is increased in idiopathic pulmonary fibrosis (IPF). Immunohistochemistry of nonfibrotic (left) and IPF (right) lung tissue demonstrating that Piezo2 (brown staining) is strongly present in ...

A recent study published by Rutgers Health experts in the European Respiratory Journal identified interconnected webs of ...

Blocking Piezo2, a protein receptor that senses mechanical forces in tissues, may be a new way to slow IPF progression, per a ...

Exploratory objectives include assessing its impact on the pathology of the disease ... be affected by the progressive interstitial lung disease, IPF. The disease is characterised by thickening ...

Munich, Germany – April 9, 2025-- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced its ...

Idiopathic pulmonary fibrosis (IPF) is a devastating progressive ... The American Journal of Pathology (2025). DOI: 10.1016/j.ajpath.2024.12.015 ...

The new study in The American Journal of Pathology, published by Elsevier ... morbidity and sometimes mortality. Idiopathic pulmonary fibrosis (IPF) is a devastating progressive fibrotic lung ...